About Index Trending news
Analyze
Top 50 Pricing
THERAVECTYS

THERAVECTYS

Work at THERAVECTYS? Add yourself to this profile

THERAVECTYS

THERAVECTYS develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.

Elsewhere

Alexa global traffic share

16 Oct 2013
$18,913,020
Venture capital (Series D)
04 Sep 2012
$9,409,092
Venture capital (Series C)
Guy PAILLAUD, John PIETERS, Philippe ODDO, +1